Medtronic recalls loading system for heart device
Medtronic Plc has recalled 6,912 units of loading system of a recently approved heart device after reports of the presence of particulates. The medical device maker said it received 8 reports related to the issue out of 7,347 potentially affected units through July 6, but no reports of "adverse patient effects". (bit.ly/1eVphqe)All affected systems have been withdrawn from the market,...
Login or Register to read the full article
Medtronic Plc has recalled 6,912 units of loading system of a recently approved heart device after reports of the presence of particulates.
The medical device maker said it received 8 reports related to the issue out of 7,347 potentially affected units through July 6, but no reports of "adverse patient effects". (bit.ly/1eVphqe)
All affected systems have been withdrawn from the market, Medtronic spokeswoman Wendy Dougherty told Reuters on Thursday, adding that no affected loading systems had been released commercially in the United States.
The U.S. Food and Drug Administration classified the recall as "Class 1", implying there is a reasonable probability that the use of or exposure to the product could cause serious side-effects or death. (1.usa.gov/1McR6cs)
The product, EnVeo R Loading System, is part of Medtronic's CoreValve Evolut R system, which was cleared for marketing in the United States in June.
The Evolut device is approved for transaortic valve replacement (TAVR) in patients with severe aortic stenosis — a condition where the aortic valve narrows — and for whom surgery is too risky.
The presence of particulates could potentially lead to the introduction of a blockage in the bloodstream, Medtronic said in a letter to customers.
The issue has been resolved with improvements in the manufacturing process, Dougherty said.
Medtronic, founded in 1949 is a world-wide leading device maker with speciality in cardiac rhythm disease management, spinal and biologics, cardiovascular, neuromodulation, surgery, diabetes, etc
The medical device maker said it received 8 reports related to the issue out of 7,347 potentially affected units through July 6, but no reports of "adverse patient effects". (bit.ly/1eVphqe)
All affected systems have been withdrawn from the market, Medtronic spokeswoman Wendy Dougherty told Reuters on Thursday, adding that no affected loading systems had been released commercially in the United States.
The U.S. Food and Drug Administration classified the recall as "Class 1", implying there is a reasonable probability that the use of or exposure to the product could cause serious side-effects or death. (1.usa.gov/1McR6cs)
The product, EnVeo R Loading System, is part of Medtronic's CoreValve Evolut R system, which was cleared for marketing in the United States in June.
The Evolut device is approved for transaortic valve replacement (TAVR) in patients with severe aortic stenosis — a condition where the aortic valve narrows — and for whom surgery is too risky.
The presence of particulates could potentially lead to the introduction of a blockage in the bloodstream, Medtronic said in a letter to customers.
The issue has been resolved with improvements in the manufacturing process, Dougherty said.
Medtronic, founded in 1949 is a world-wide leading device maker with speciality in cardiac rhythm disease management, spinal and biologics, cardiovascular, neuromodulation, surgery, diabetes, etc
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd